Online citations, reference lists, and bibliographies.
← Back to Search

Recommendations Of The Panel On Cost-effectiveness In Health And Medicine.

M. Weinstein, J. Siegel, M. Gold, M. Kamlet, L. Russell
Published 1996 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
OBJECTIVE To develop consensus-based recommendations for the conduct of cost-effectiveness analysis (CEA). This article, the second in a 3-part series, describes the basis for recommendations constituting the reference case analysis, the set of practices developed to guide CEAs that inform societal resource allocation decisions, and the content of these recommendations. PARTICIPANTS The Panel on Cost-Effectiveness in Health and Medicine, a nonfederal panel with expertise in CEA, clinical medicine, ethics, and health outcomes measurement, was convened by the US Public Health Service (PHS). EVIDENCE The panel reviewed the theoretical foundations of CEA, current practices, and alternative methods used in analyses. Recommendations were developed on the basis of theory where possible, but tempered by ethical and pragmatic considerations, as well as the needs of users. CONSENSUS PROCESS The panel developed recommendations through 2 1/2 years of discussions. Comments on preliminary drafts prepared by panel working groups were solicited from federal government methodologists, health agency officials, and academic methodologists. CONCLUSIONS The panel's methodological recommendations address (1) components belonging in the numerator and denominator of a cost-effectiveness (C/E) ratio; (2) measuring resource use in the numerator of a C/E ratio; (3) valuing health consequences in the denominator of a C/E ratio; (4) estimating effectiveness of interventions; (5) incorporating time preference and discounting; and (6) handling uncertainty. Recommendations are subject to the ¿rule of reason,¿ balancing the burden engendered by a practice with its importance to a study. If researchers follow a standard set of methods in CEA, the quality and comparability of studies, and their ultimate utility, can be much improved.
This paper references
10.2165/00128413-199308740-00001
Prevention better than cure
A. Ruf (1973)
10.7326/0003-4819-87-1-135
Hypertension: A Policy Perspective
M. Weinstein (1976)
10.1016/0038-0121(76)90036-7
Social preferences for health states: An empirical evaluation of three measurement techniques
G. Torrance (1976)
Preferences for health out$ comes : comparison of assessment methods
JL Read (1976)
10.1056/NEJM197703312961304
Foundations of cost-effectiveness analysis for health and medical practices.
M. Weinstein (1977)
10.1287/OPRE.30.6.1043
Application of Multi-Attribute Utility Theory to Measure Social Preferences for Health States
G. Torrance (1982)
10.1177/0272989X8400400307
Preferences for Health Outcomes
J. Read (1984)
Preferences for health out-$ comes: comparison of assessment methods
JL Read (1984)
Is Prevention Better Than Cure? Washington, DC: Brookings Institution
LB Russell (1986)
10.1136/jech.41.4.355-a
Methods for the economic evaluation of health care programmes
S. Wilson (1987)
A general health policy model: update and applications.
R. Kaplan (1988)
10.1017/S0266462300008461
Utilities and quality-adjusted life years.
G. Torrance (1989)
10.1016/0168-8510(90)90421-9
EuroQol--a new facility for the measurement of health-related quality of life.
A. Kasuya (1990)
EuroQol : a new facility for the measurement of health-related quality of life
A. Williams (1990)
10.1097/00005650-199206000-00002
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
J. Ware (1992)
10.1257/JEP.6.3.3
Medical care costs: how much welfare loss?
J. Newhouse (1992)
THE MOS 36- ITEM SHORT FORM HEALTH SURVEY (SF- 36) CONCEPTUAL FRAMEWORK AND ITEM SELECTION
Ware J.E.Jr. (1992)
10.1016/0277-9536(92)90211-8
Methods for quality adjustment of life years.
E. Nord (1992)
10.1056/NEJM199207023270102
Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction.
H. Krumholz (1992)
10.7326/0003-4819-116-3-238
Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly?
I. Udvarhelyi (1992)
Health Status and Health Policy: AllocatingResources toHealth Care
DL Patrick (1993)
10.1093/OXFORDJOURNALS.AJE.A116969
Health Status and Health Policy: Allocating Resources to Health Care
M. Morgan (1994)
10.1016/0167-6296(94)00044-5
The friction cost method for measuring indirect costs of disease.
M. Koopmanschap (1995)
10.1037/E583992012-001
Years of healthy life.
P. Erickson (1995)
Years of Healthy Life. Hyattsville, Md: Centers for Disease Control and Prevention, National Center for Health Statistics
P Erickson (1995)
10.1001/JAMA.1996.03540140060028
The Role of Cost-effectiveness Analysis in Health and Medicine
L. Russell (1996)
10.1093/acprof:oso/9780190492939.001.0001
Cost-effectiveness in health and medicine
M. Gold (1996)
Panel on cost-effectiveness in health and medicine.
M. Gold (1996)
for the Panel on Cost-Effectiveness in Health and Medicine. The role of cost-effectiveness analysis in health and medicine
L B Russell (1996)
10.1016/s0167-6296(96)00506-1
Economic foundations of cost-effectiveness analysis.
A. Garber (1997)
10.3386/w5946
Accounting for Future Costs in Medical Cost-Effectiveness Analysis
D. Meltzer (1997)
for the Panel on Cost-Effectiveness in Health and Medicine. Recommendations for reporting cost-effectiveness analyses
J E Siegel



This paper is referenced by
10.1016/j.ypmed.2021.106469
Cost evaluation of tobacco control interventions in clinical settings: A systematic review.
R. Salloum (2021)
10.1007/s11325-021-02362-8
Economic evaluation of CPAP therapy for obstructive sleep apnea: a scoping review and evidence map
D. Pachito (2021)
10.1177/1758573221990367
Plate fixation of midshaft clavicle fractures for delayed union and non-union is a cost-effective intervention but functional deficits persist at long-term follow-up
B. Fox (2021)
10.2106/JBJS.RVW.20.00124
Understanding Health Economics in Spine Surgery.
Shyam A Patel (2021)
10.1007/s41669-021-00267-6
Cost-effectiveness of a Province-wide Quality Improvement Initiative for Reducing Potentially Inappropriate Use of Antipsychotics in Long-Term Care in British Columbia, Canada
A. Khowaja (2021)
10.1097/CCM.0000000000004851
Health-Related Quality-of-Life and Cost Utility Analyses in Critical Care: A Systematic Review*
V. Lau (2021)
10.1001/jamanetworkopen.2021.4846
Cost-effectiveness of Atezolizumab Plus Bevacizumab vs Sorafenib for Patients With Unresectable or Metastatic Hepatocellular Carcinoma
Xin Zhang (2021)
10.1016/j.vhri.2020.06.002
A Study Comparing Cost-Effectiveness of Combination Therapy for Preventing Opportunistic Infections Among Human Immunodeficiency Virus-Infected Adults on Antiretroviral Therapy.
G. Grover (2021)
10.3389/fphar.2021.718014
Cost-Effectiveness of Frontline Treatment for Advanced Renal Cell Carcinoma in the Era of Immunotherapies
SiNi Li (2021)
10.1002/alz.12262
The economic cost of delirium: A systematic review and quality assessment
I. Kinchin (2021)
10.1007/s41669-021-00273-8
The Utility of Economic Measures to Quantify the Burden of Tinnitus in Affected Individuals: A Scoping Review
Elza Daoud (2021)
10.1016/j.jctube.2021.100262
Cost effectiveness of three months of rifapentine and isoniazid for latent tuberculosis in Syrian refugees
Ghassan Ilaiwy (2021)
10.1532/hsf.3261
Health-Related Quality of Life of Coronary Artery Disease Patients under Secondary Prevention: A Cross-Sectional Survey from South India.
R. Sudevan (2021)
10.1007/978-3-030-48080-6
Medical Quality Management: Theory and Practice
A. Giardino (2021)
10.1136/bmjopen-2021-051226
Preoperative contingency management intervention for smoking abstinence in cancer patients: trial protocol for a multisite randomised controlled trial
Alana M Rojewski (2021)
10.1177/1758573219897860
Cost-effectiveness of the reverse total shoulder arthroplasty. Does indication affect outcome?
J. Nicholson (2021)
10.1007/s00586-021-06725-3
Association between the appropriateness of surgery, according to appropriate use criteria, and patient-rated outcomes after surgery for lumbar degenerative spondylolisthesis
A. Mannion (2021)
10.1371/journal.pone.0245963
Comparison of (Partial) economic evaluations of transforaminal lumbar interbody fusion (TLIF) versus Posterior lumbar interbody fusion (PLIF) in adults with lumbar spondylolisthesis: A systematic review.
Inge J M H Caelers (2021)
10.4070/kcj.2021.0051
Cost-Effectiveness Analysis of Hypertension Screening in the Korea National Health Screening Program
Hae-Young Lee (2021)
Health Information Resources and Clinical Core Skills as Predictors of Medical Doctors Clinical Decision Making in Obafemi Awolowo University Teaching Hospital, Ile-Ife, Nigeria
(2021)
10.1016/j.ajem.2021.08.037
Cost-effectiveness of field trauma triage among injured children transported by emergency medical services.
D. Nishijima (2021)
10.1302/2058-5241.6.200115
Understanding cost-utility analysis studies in the trauma and orthopaedic surgery literature
Achi Kamaraj (2021)
10.1007/s10198-021-01286-0
Evaluating the conduct and application of health utility studies: a review of critical appraisal tools and reporting checklists
M. Zoratti (2021)
10.1016/j.ygyno.2021.02.020
The levonorgestrel intrauterine system for prevention of endometrial cancer in women with obesity: A cost-effectiveness study.
L. Bernard (2021)
10.1016/j.breast.2021.04.002
Cost-effectiveness of postmastectomy hypofractionated radiation therapy vs conventional fractionated radiation therapy for high-risk breast cancer
Jing Yang (2021)
10.1007/s41669-021-00298-z
A Systematic Review of Cost-Effectiveness Analyses for Hepatocellular Carcinoma Treatment
Sydney C. Yuen (2021)
10.1016/j.arthro.2021.01.026
Current Orthopaedic Health Economic Literature: Quality is High but Ethical and Societal Perspectives are Lacking.
J. Lamplot (2021)
10.1001/jamanetworkopen.2021.13969
Availability of Cost-effectiveness Studies for Drugs With High Medicare Part D Expenditures
Rebecca L Tisdale (2021)
10.1111/mcn.13118
Economic evaluation of a reduced dosage of ready‐to‐use therapeutic foods to treat uncomplicated severe acute malnourished children aged 6–59 months in Burkina Faso
D. S. N'Diaye (2021)
10.1016/j.socscimed.2021.113692
Cost-effectiveness analysis of housing first intervention with an independent housing and team support for homeless people with severe mental illness: A Markov model informed by a randomized controlled trial.
C. Lemoine (2021)
10.1093/cid/ciab442
Rotavirus vaccination likely to be cost saving to society in the United States.
A. Newall (2021)
10.1007/978-3-030-39903-0_300428
Cost-Effectiveness Analysis
S. Beyer (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar